drugset / Trial / NCT07486583

Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.

NCT07486583

Phase 3 Not yet recruiting 40 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.

Timeline

Start
2026-04-30
Primary completion
2026-09-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Background Desloratadine Small molecule 10 mg